Literature DB >> 7953322

Distribution of the major xenoantigen (gal (alpha 1-3)gal) for pig to human xenografts.

I F McKenzie1, P X Xing, H A Vaughan, J Prenzoska, P L Dabkowski, M S Sandrin.   

Abstract

We have previously demonstrated that the major epitope in pig tissues detected by naturally occurring human IgM antibodies is galactose (alpha 1-3)galactose. Subsequent biochemical studies demonstrated this epitope to be present on molecules (Mr40-220kDa) on both endothelial cells and lymphocytes. The objective of the present study was to define the distribution of gal(alpha 1-3)gal in different pig tissues, concentrating on those of relevance for the potential transplantation of pig organs or tissues to humans. Adult pig tissues were obtained fresh, fixed, and stained by the immunoperoxidase technique using biotinylated Griffonia simplicifolia lectin (IB4) which binds only to gal(alpha 1-3)gal, and examined histologically. Endothelial cells in all small vessels (capillaries, arterioles and venules) had a unifrom and dense expression of gal(alpha 1-3)gal; in larger vessels, like the aorta, they were less reactive. The highest concentrations were found in the liver parenchyma which stained uniformly, and in the kidney, where the highest amounts were found in the brush border of the proximal convoluted tubules. There was no staining of collecting ducts or glomeruli (except for endothelium) and moderate staining of the distal convoluted tubules. Heart muscle was nonreactive, although the high density of capillaries indicated a reasonable content of gal(alpha 1-3)gal. In contrast to these tissues was the distribution in the pancreas, which, apart from vessels and the lining of ducts, was nonreactive, i.e. islet cells were essentially lacking in gal(alpha 1-3)gal. Other tissues such as the lung contained moderate amounts of material lining the alveoli and bronchioles.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7953322     DOI: 10.1016/0966-3274(94)90032-9

Source DB:  PubMed          Journal:  Transpl Immunol        ISSN: 0966-3274            Impact factor:   1.708


  14 in total

Review 1.  Islets transplanted in immunoisolation devices: a review of the progress and the challenges that remain.

Authors:  Esther S O'Sullivan; Arturo Vegas; Daniel G Anderson; Gordon C Weir
Journal:  Endocr Rev       Date:  2011-09-27       Impact factor: 19.871

2.  Role for CD47-SIRPalpha signaling in xenograft rejection by macrophages.

Authors:  Kentaro Ide; Hui Wang; Hiroyuki Tahara; Jianxiang Liu; Xiaoying Wang; Toshimasa Asahara; Megan Sykes; Yong-Guang Yang; Hideki Ohdan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-12       Impact factor: 11.205

3.  Natural human anti-Gal alpha(1,3)Gal antibodies react with human mucin peptides.

Authors:  M S Sandrin; H A Vaughan; P X Xing; I F McKenzie
Journal:  Glycoconj J       Date:  1997-01       Impact factor: 2.916

4.  Functionally important glycosyltransferase gain and loss during catarrhine primate emergence.

Authors:  Chihiro Koike; Monica Uddin; Derek E Wildman; Edward A Gray; Massimo Trucco; Thomas E Starzl; Morris Goodman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-28       Impact factor: 11.205

Review 5.  Overcoming the barriers to xenotransplantation: prospects for the future.

Authors:  Burcin Ekser; David K C Cooper
Journal:  Expert Rev Clin Immunol       Date:  2010-03       Impact factor: 4.473

6.  A desirable transgenic strategy using GGTA1 endogenous promoter-mediated knock-in for xenotransplantation model.

Authors:  Nayoung Ko; Joohyun Shim; Hyoung-Joo Kim; Yongjin Lee; Jae-Kyung Park; Kyungmin Kwak; Jeong-Woong Lee; Dong-Il Jin; Hyunil Kim; Kimyung Choi
Journal:  Sci Rep       Date:  2022-06-10       Impact factor: 4.996

7.  Identification of the V genes encoding xenoantibodies in non-immunosuppressed rhesus monkeys.

Authors:  Annette Kleihauer; Clare R Gregory; Dominic C Borie; Andrew E Kyles; Irina Shulkin; Insiyyah Patanwala; Joanne Zahorsky-Reeves; Vaughn A Starnes; Yoko Mullen; Ivan T Todorov; Mary Kearns-Jonker
Journal:  Immunology       Date:  2005-09       Impact factor: 7.397

Review 8.  Current status of xenotransplantation and prospects for clinical application.

Authors:  Richard N Pierson; Anthony Dorling; David Ayares; Michael A Rees; Jörg D Seebach; Jay A Fishman; Bernhard J Hering; David K C Cooper
Journal:  Xenotransplantation       Date:  2009 Sep-Oct       Impact factor: 3.907

Review 9.  Immune modulation in xenotransplantation.

Authors:  Magdalena Boksa; Joanna Zeyland; Ryszard Słomski; Daniel Lipiński
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2014-10-30       Impact factor: 4.291

10.  Expression of recipient CD47 on rat insulinoma cell xenografts prevents macrophage-mediated rejection through SIRPα inhibitory signaling in mice.

Authors:  Yoshifumi Teraoka; Kentaro Ide; Hiroshi Morimoto; Hiroyuki Tahara; Hideki Ohdan
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.